Evaluation of serum Mucorales PCR for the diagnosis of Mucormycoses: The MODIMUCOR prospective trial.
Fiche publication
Date publication
janvier 2022
Journal
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Auteurs
Membres identifiés du Cancéropôle Est :
Dr BERCEANU Ana, Dr CAILLOT Denis, Pr HERBRECHT Raoul
Tous les auteurs :
Millon L, Caillot D, Berceanu A, Bretagne S, Lanternier F, Morio F, Letscher-Bru V, Dalle F, Denis B, Alanio A, Boutoille D, Bougnoux ME, Botterel F, Chouaki T, Charbonnier A, Ader F, Dupont D, Bellanger AP, Rocchi S, Scherer E, Gbaguidi-Haore H, Herbrecht R
Lien Pubmed
Résumé
Early diagnosis and prompt initiation of specific antifungal treatment is essential for improving the prognosis of mucormycosis. We aimed to assess the performance of serum Mucorales quantitative PCR (qPCR) for the early diagnosis and follow-up of mucormycosis.
Mots clés
Mucorales quantitative PCR, Mucormycosis, circulating DNA, molecular diagnosis
Référence
Clin Infect Dis. 2022 Jan 5;: